Lupin Limited has informed the Exchange regarding a press release dated September 28, 2026, titled “Lupin Receives Tentative Approval from U.SFDA for Novel Apixaban Oral Suspension”|SUBJECT: Press Release
Source link
Revolutionary taking place
Revolutionary taking place
Lupin Limited has informed the Exchange regarding a press release dated September 28, 2026, titled “Lupin Receives Tentative Approval from U.SFDA for Novel Apixaban Oral Suspension”|SUBJECT: Press Release
Source link